re: 5. listing on aim, uk capital raising + To List on...

re: 5. listing on aim, uk capital raising + To List on AIM/Capital Raising & EGM Notification:
http://stocknessmonster.com/news-item?S=EPT&E=ASX&N=234534

Extract:
EpiTan to list on London’s Alternative Investment Market (AIM) and raise up to A$37 million for Phase III clinical trials
Melbourne, Australia

EpiTan Limited (ASX: EPT, ADR: EPTNY, XETRA: UR9) today announced its intention to seek admission of its shares to trading on the Alternative Investment Market of the London Stock Exchange (AIM) and to undertake an institutional capital raising in the UK.
The capital raising will seek to raise up to £15 million (approx A$37 million).

Teather & Greenwood Limited has been engaged as the company’s nominated advisors and brokers and is assisting the company with its AIM admission and capital raising.
Teather & Greenwood Limited is one of the UK's leading stockbrokers, with 114 retained clients. It is strategically focused on the small and mid-cap sectors. In the calendar year ended 31 December 2004 Teather & Greenwood's corporate finance department undertook
41 transactions with a total equity value of £1.03 billion.
The company believes two major benefits will result from the listing on AIM and the capital
raising:
• Having funds which are expected to enable completion of the remaining clinical
(Phase II and III) and non-clinical development of MELANOTAN™, with a view to obtaining regulatory approval.
• Enhancing the company’s profile internationally.

Furthermore, the capital raising is an important component of the company’s strategy because it aims to create a sufficient pool of securities in the UK to provide significant liquidity for the AIM market.

EpiTan Limited abn 88 089 644 119
Level 13, 1 Collins Street, Melbourne Victoria 3000 Australia Telephone +61 3 9660 4900 Facsimile +61 3 9660 4999 www.epitan.com.au